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Background: The SCORE (Systematic COronary Risk Evaluation) scale uses conventional risk factors for the prediction of
the 10-year risk of fatal atherosclerotic cardiovascular disease (CVD). The high-risk version of SCORE is recommended by
the European Society of Cardiology for use in the populations of Central and Eastern Europe and former Soviet Union
(CEE/FSU). Given the role of hazardous alcohol consumption as an important determinant of CVD mortality in CEE/FSU
men, this study investigated whether adding hazardous drinking characteristics to the high-risk SCORE improves
its prognostic performance in contemporary population-based male CEE/FSU cohorts.
Methods: The HAPIEE (Health, Alcohol, and Psychosocial factors In Eastern Europe) study follows Czech (seven
towns), Polish (Krakow), and Russian (Novosibirsk) cohorts from 2002–2005. In HAPIEE men (n = 8,927), 264
atherosclerotic cardiovascular deaths were registered over the median follow-up time of 6.2-8.1 years.
Results: In HAPIEE men, the baseline levels of the high-risk SCORE ≥5% significantly predicted fatal CVD. After
controlling for the high-risk SCORE, binge drinking (drinking ≥100 g of ethanol at least once a month) and
problem drinking (≥2 positive answers to CAGE questionnaire) were inconsistently associated with fatal CVD.
No marked improvement in calibration and discrimination was observed for the high-risk SCORE extended by
these hazardous drinking indicators, and all values of integrated discrimination improvement were <0.5%.
Conclusions: Extending the high-risk SCORE by hazardous drinking parameters failed to improve its prognostic
performance across male CEE/FSU population samples. Our findings tentatively support the use of the original
high-risk SCORE in male CEE/FSU populations. More research is needed on the potential use of hazardous drinking in
cardiovascular risk prediction.
Keywords: Cardiovascular mortality and risk factors, SCORE scale, Hazardous drinking, Central and Eastern Europe,
Former Soviet UnionBackground
The SCORE (Systematic COronary Risk Evaluation) scale
is a widely used instrument for assessing the risk of future
cardiovascular disease (CVD) across European popula-
tions [1]. SCORE uses the information on age, gender,
blood lipids, blood pressure (BP), and smoking in order to* Correspondence: o.vikhireva@ucl.ac.uk
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spectively. The European Society of Cardiology (ESC)
recommends applying the high-risk SCORE to the pop-
ulations of Central and Eastern Europe (CEE) and former
Soviet Union (FSU) [2], even though this version was
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the SCORE prognostic performance by adding resting
heart rate [3], high-density lipoprotein cholesterol [4], and
other factors [5,6] to the model based on conventional
risk determinants. Across CEE/FSU populations, which
still face high levels of CVD mortality [7], male hazardous
alcohol consumption is one of the potential candidates for
inclusion in cardiovascular risk models, together with con-
ventional risk factors [7-10]. Although several standar-
dised instruments for the hazardous drinking assessment
exist, the prognostic performance of alcohol-extended
CVD risk scales has never been examined in CEE/FSU.
Our study aimed to investigate whether the high-risk
SCORE calibration and discrimination in men improve
after extension by hazardous drinking characteristics, using
the individual-level data from three contemporary
population-based CEE/FSU cohorts.
Methods
Study population and samples
The HAPIEE (Health, Alcohol, and Psychosocial factors
In Eastern Europe) study is an ongoing multi-centre
study of CVD and other chronic conditions in CEE/
FSU [11]. It follows random population samples from the
Czech Republic (Havířov/Karviná, Hradec Králové, Jihlava,
Kroměříž, Liberec, and Ústí nad Labem), Poland (Krakow),
Russia (Novosibirsk), and Lithuania (Kaunas) since the
baseline assessment (2002–2005; 2006–2008 in Kaunas)
for cause-specific mortality and non-fatal CVD. As the
Lithuanian cohort entered the study later and had fewer
CVD deaths, it was excluded from the present analyses.
The numbers of sampled and examined male subjects,
baseline examination years, and response rates are pre-
sented in Table 1. At baseline, a questionnaire survey and a
physical examination, with a fasting venous blood sample
collection, were performed. Mortality data were obtained
from national (the Czech Republic) and local (Poland and
Russia) registers [11]. The adjudication process for CVD
deaths in HAPIEE was extensive, combining data from
death certificates with information from CVD registers,










Recruited, N 4,124 5,230 4,269
Within the study age range, N 4,077 5,230 4,264
No pre-existing CVD, N 3,405 3,986 3,254
No missing SCORE values, N 2,659 3,456 3,246
No missing values of SCORE and
binge and problem drinking, N
2,517 3,196 3,214analyses, the follow-up time was until the end of 2011
for the Czech Republic and the end of 2010 for Poland
and Russia, or the date of death, or the date of last con-
tact for those lost to follow-up. The percentage of par-
ticipants lost to follow-up was lowest in Russia (1%) and
highest in Poland (5%), mainly due to withdrawal from the
study.
As SCORE predicts cardiovascular risk in individuals
over 40 and without pre-existing atherosclerotic CVD [1],
we excluded subjects aged <40 at baseline and those
with medical evidence or a self-reported history of doctor-
diagnosed myocardial infarction, angina, or stroke. In
Czech and Polish samples, the study questionnaire was
completed at home, prior to medical examination in a
clinic. This explains the smaller proportion of Czech and
Polish participants with non-missing data. Relatively few
women reported hazardous drinking, therefore, only men
were included in these analyses. Overall, 8,927 men had
available data on baseline SCORE levels and hazardous
drinking characteristics (Table 1).
The HAPIEE protocol was approved by the University
College London/University College London Hospital Ethics
Committee (London, UK) and by local ethics commit-
tees at each study centre: the National Institute of Public
Health Ethics Committee (Prague, the Czech Republic),
the Jagellonian University Ethics Committee (Krakow,
Poland), and the Institute of Internal and Preventive
Medicine Ethics Committee (Novosibirsk, Russia) [11].
All participants provided written informed consent.
Measurements
The SCORE risk predictors include age, sex, smoking
status, total cholesterol (TC), and systolic BP (SBP). The
measurement of these parameters in HAPIEE participants
is described in detail elsewhere [11,12]. Individuals cur-
rently and regularly smoking at least one cigarette per day
were classified as current smokers; never and ex-smokers
were considered non-smokers, according to the SCORE
criteria [1]. SBP and TCH measurement was subjected to
extensive quality control.
Our additional risk factors of interest were binge drinking
and problem drinking (positive CAGE score) [11]. Annual
alcohol consumption and drinking patterns in HAPIEE
were estimated by the graduated frequency (GF) method
[13,14], which assesses how often during the past 12 months
more than a specific amount of alcohol (approximately 0.5
drinks, 1–2, 3–4, 5–6, 7–9, or ≥10 drinks) was consumed;
the frequency is measured on a nine-point scale, ranging
from “never” to “every day”. Based on the GF data, we de-
fined male binge drinking as consumption of ≥100 g of
ethanol per drinking session at least once a month. The
presence of alcohol-related problems in the last 12 months
was assessed by the CAGE questionnaire [15], which asked
whether the person had felt he/she should cut down on
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criticising his/her drinking; whether the person had felt bad
or guilty about his/her drinking; and whether he/she had a
drink first thing in the morning. Participants with ≥2 posi-
tive answers were considered problem drinkers.
In line with SCORE end-points [1], the study outcome
was atherosclerotic cardiovascular death (International
Classification of Diseases 10 codes: I10-I15, I20-I25, I44-
I73 (except I45.6, I51.4, I52, I60, I62, I67.1, I67.5 and
I67.7), R96.0, and R96.1).
Statistical analyses
We used the high-risk SCORE version, which is recom-
mended by the ESC for CEE/FSU populations [2], to
predict the risk of fatal atherosclerotic CVD in all male
HAPIEE samples. The recently introduced Czech and Pol-
ish SCORE versions were not used, as they lack a detailed
description of their development and recalibration and are
very similar to the original high-risk SCORE scale [16,17].
The prognostic performance of risk prediction scales,
such as SCORE, is assessed via calibration and discrim-
ination [18,19]. Calibration shows how close the predicted
and observed risks are. Discrimination demonstrates how
accurately the participants who will experience events
(such as fatal CVD) during the follow-up are separated
from those who will remain event-free. Better calibration
and discrimination are denoted, respectively, by lower χ2
values and higher p-values in the Hosmer-Lemeshow test
[20] and higher values of the Harrell’s C-statistic [21]. The
additional prognostic value of extra risk predictors could
be assessed in likelihood ratio tests (LRT). Lower LRT
p-values signify more pronounced differences between
the nested baseline and extended models and, therefore,
better predictive performance of the latter. Recently in-
troduced and more clinically relevant parameters of risk
reclassification are net reclassification index and integrated
discrimination improvement (IDI). As our additional risk
factors were dichotomized and, hence, specific to HAPIEE
samples, we used IDI, which is relatively independent of
risk cut-offs and categories and reflects the ability of
the extended model to improve average sensitivity with-
out compromising average specificity [22,23].
We performed our analyses of the prognostic ability of
the extended high-risk SCORE separately in each sam-
ple. Our extended models included hazardous drinking
parameters and SCORE values calculated with the high-
risk SCORE chart (an equivalent of assessing drinking
patterns of an individual after calculating their SCORE
risk levels). A similar approach was used in some other
studies of the extended SCORE [5,6], and it was demon-
strated that the models with calculated SCORE values and
those with fitted SCORE variables perform similarly [5]. In
our analyses, we first explored the role of high-risk SCORE,
binge drinking, and problem drinking as cardiovascularmortality predictors, using Cox regression models. Then
we estimated calibration and discrimination of the high-
risk SCORE extended by hazardous drinking parameters,
calculating Hosmer-Lemeshow χ2, Harrell’s C, LRT p,
and IDI. The baseline Model 1 (high-risk SCORE only)
was compared to Model 2 (high-risk SCORE and binge
drinking), Model 3 (high-risk SCORE and problem drink-
ing), and Model 4 (high-risk SCORE, binge drinking, and
problem drinking). We were aware that the relatively small
number of atherosclerotic CVD deaths in Czech and Polish
samples could affect the prognostic performance of the ex-
tended high-risk SCORE. Therefore, the results for these
samples should be interpreted with caution.
The use of Cox proportional hazards regression models
was justified by the high p-values in Schoenfeld’s test. The
competing-risk regression analyses [24], which take into ac-
count the risk of death from causes other than atheroscler-
otic CVD, produced very similar results (not presented) to
those of standard Cox analyses. No significant interactions
between the high-risk SCORE and hazardous drinking
indicators were detected. In HAPIEE samples, alcohol
consumption frequency demonstrated a J- or U-shaped
association with fatal CVD (not presented). The avail-
able HAPIEE data did not permit the differentiation be-
tween never-drinkers and ex-drinkers, and excluding all
self-reported never-drinkers would substantially reduce
the sample size. Therefore, our analyses focused on binge
and problem drinking. Simultaneously extending the high-
risk SCORE by these two variables was possible, due to
low values of phi correlation coefficient (not presented).
To enable comparisons between non-extended and ex-
tended models, the analyses included only subjects with
known values of SCORE and hazardous drinking charac-
teristics. The high-risk SCORE calibration was affected by
the fact that the current follow-up of HAPIEE samples is
less than 10 years (Table 2). However, our focus was on
the calibration changes after the high-risk SCORE exten-
sion by binge and problem drinking, rather than on
SCORE calibration per se. As the Hosmer-Lemeshow test
quantifies the agreement between predicted and observed
events across risk deciles, it was applied to the non-
dichotomised high-risk SCORE, which treats individual
levels of absolute risk (percentages in the respective
SCORE chart cells) as a continuous variable. All statistical
analyses were performed using Stata/IC 12.0 (StataCorp
LP, Texas, USA).
Results
Description of the study samples
The characteristics of male HAPIEE samples are presented
in Table 2. At baseline, the mean age of participants was
close to 57 years, with relatively similar sizes of the five-
year age groups. Smoking prevalence was higher in Russian
men (>50%), compared to Czech and Polish men (<35%).




N 2,517 3,196 3,214
Mean age (SD), years 57.9 (7.1) 57.1 (6.9) 57.5 (7.0)
Age groups, %
45-49 17.4 20.6 18.9
50-54 20.0 21.4 21.3
55-59 20.8 21.8 21.6
60-64 21.3 18.5 18.2
65+ 20.6 17.8 20.0
Current smoking, % 26.6 33.1 51.2
Mean TC (SD), mmol/l 5.7 (1.0) 5.8 (1.1) 6.0 (1.2)
Mean SBP (SD), mm Hg 143.7 (18.5) 141.6 (20.2) 141.6 (22.6)
Binge drinking, % 18.1 9.7 33.0
Problem drinking, % 10.0 9.2 20.8
Median follow-up (IQR), years 8.1 (7.7-8.9) 7.1 (6.9-7.7) 6.2 (5.7-7.0)
Atherosclerotic cardiovascular
deaths, N (%)
60 (2.4) 55 (1.7) 159 (5.0)
IQR, interquartile range; SBP, systolic blood pressure; SD, standard deviation;
TC, total cholesterol.
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The highest mean SBP levels (144 mm Hg) were observed
for Czech men. The hazardous drinking prevalence in
Russian men was twice as high as in their Czech and
Polish counterparts. Despite the shortest follow-up period,
the percentage of atherosclerotic CVD deaths in Russian
men (5%) was higher than that in Czech and Polish
men (2%).
SCORE performance and hazardous drinking
In all HAPIEE samples, the baseline high-risk SCORE ≥5%
significantly predicted the risk of CVD mortality over the
subsequent 6.2-8.1 years, both before and after adjustment
for hazardous drinking (adjusted HR 3.6-8.6; Table 3). Due
to the current follow-up being under 10 years, the sample-
specific numbers of CVD deaths were relatively low, and
95% confidence intervals were wide. There was little evi-
dence that either parameter of hazardous drinking is a
significant predictor of fatal CVD after adjustment for
high-risk SCORE. In Polish men, problem drinking ap-
peared a significant predictor of fatal CVD even after
adjustment for high-risk SCORE and binge drinking,
but this sample had the lowest number of atherosclerotic
cardiovascular deaths (n = 55).
Hosmer-Lemeshow χ2 values were relatively low for the
original high-risk SCORE, with Russian men as the only
exception. The high-risk SCORE extension by binge or
problem drinking only slightly reduced, or even increased,
χ2 values and, therefore, demonstrated either minimal or
no calibration improvement.For all samples, the inclusion of binge and problem
drinking in the high-risk SCORE resulted in a modest
increase in Harrell’s C-statistics. This increase was the
most pronounced in Polish men (from 0.63 for Model 1
to 0.66 for Model 4). All LRT p-values were relatively
high: the lowest ones were observed in Polish men (0.03;
Model 3). The degree of discrimination improvement,
quantified by IDI, was below 0.5% in all samples. Over-
all, calibration and discrimination of the original, non-
extended high-risk SCORE appeared to be similar, or only
marginally worse, compared to the performance of the high-
risk SCORE extended by hazardous drinking indicators.
Discussion
To the best of our knowledge, this is the first attempt to
investigate the prognostic performance of the high-risk
SCORE extended by hazardous drinking in CEE/FSU male
population samples. The high-risk SCORE significantly
predicted atherosclerotic cardiovascular mortality in
HAPIEE men, both before and after adjustment for haz-
ardous alcohol consumption. On the other hand, adding
binge and problem drinking to the high-risk SCORE did
not substantially improve its calibration and discrimin-
ation, which supports the use of the original, non-extended
instrument.
Strengths and limitations
Several methodological issues should be considered when
interpreting our results. First, although HAPIEE samples
are not representative of the whole countries, they are the
best available CEE/FSU sources of individual-level cohort
data on the levels of cardiovascular risk factors and fatal
CVD in the 2000s.
Second, as in most studies, HAPIEE participants were
likely to be healthier than non-responders to the baseline
survey and those lost to follow-up. This possible discrep-
ancy could be enhanced by the complete case analyses
and dilute the association of interest. The available mul-
tiple imputation methods employ the assumption of data
missing (completely) at random [25,26], which was un-
likely to be met in our samples. In addition, the Cox
regression results across the samples with the highest
SCORE missingness were similar for complete and multiply
imputed data (not presented). Therefore, the possible selec-
tion bias due to non-response and SCORE missingness was
unlikely to substantially affect the strength of the associ-
ation between cardiovascular risk factors and mortality.
Third, binge drinking and problem drinking are only two
parameters out of the wide range of alcohol consumption
characteristics which potentially influence cardiovascular
risk. On the other hand, the comparability, validity, and
reliability of binge and problem drinking as hazardous
alcohol consumption parameters have been previously
demonstrated for male HAPIEE populations [27]. The
Table 3 Prognostic performance of the high-risk SCORE before and after inclusion of binge and problem drinking
Czech Republic Poland Russia
Model 1 (SCORE only)
SCORE HR (95% CI) 8.64 (3.13-23.82) 3.50 (1.71-7.14) 7.00 (3.69-13.28)
Hosmer-Lemeshow χ2 (p)a 9.21 (0.33) 5.98 (0.54) 46.71 (<0.01)
Harrell’s C 0.6586 0.6262 0.6276
Model 2 (SCORE and binge drinking)
SCORE HR (95% CI) 8.56 (3.11-23.62) 3.50 (1.71-7.15) 6.99 (3.69-13.27)
Binge drinking HR (95% CI) 0.74 (0.35-1.55) 1.36 (0.62-3.01) 1.15 (0.83-1.59)
Hosmer-Lemeshow χ2 (p)a 11.07 (0.20) 7.57 (0.48) 38.61 (<0.01)
Harrell’s C 0.6694 0.6321 0.6404
LRT p 0.40 0.46 0.40
IDI, % (p) 0.039 (0.32) 0.013 (0.68) 0.043 (0.27)
Model 3 (SCORE and problem drinking)
SCORE HR (95% CI) 8.62 (3.12-23.76) 3.57 (1.75-7.30) 7.00 (3.69-13.28)
Problem drinking HR (95% CI) 0.64 (0.23-1.77) 2.34 (1.18-4.65) 1.21 (0.84-1.74)
Hosmer-Lemeshow χ2 (p)a 8.82 (0.36) 14.85 (0.06) 38.27 (<0.01)
Harrell’s C 0.6674 0.6525 0.6364
LRT p 0.36 0.03 0.32
IDI, % (p) 0.053 (0.15) 0.220 (0.09) 0.041 (0.33)
Model 4 (SCORE, binge drinking, and problem drinking)
SCORE HR (95% CI) 8.56 (3.10-23.61) 3.60 (1.75-7.30) 7.00 (3.69-13.27)
Binge drinking HR (95% CI) 0.79 (0.37-1.71) 0.98 (0.41-2.32) 1.10 (0.77-1.56)
Problem drinking (95% CI) 0.69 (0.24-1.97) 2.36 (1.12-4.97) 1.16 (0.79-1.72)
Hosmer-Lemeshow χ2 (p)a 11.68 (0.17) 15.20 (0.06) 38.86 (<0.01)
Harrell’s C 0.6705 0.6611 0.6443
LRT p 0.54 0.09 0.53
IDI, % (p) 0.071 (0.13) 0.219 (0.09) 0.060 (0.21)
CI, confidence interval; IDI, integrated discrimination improvement; HR, hazard ratio; LRT, likelihood ratio test. aCalculated for continuous high-risk SCORE.
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underestimating the actual consumption, satisfactorily
reflect the ranking of participants in terms of their drink-
ing behaviour. Their inclusion in the high-risk SCORE
was justified by the findings of several previous studies on
heavy or hazardous drinking as an important cause of car-
diovascular mortality in CEE/FSU [8-10].
Fourth, across HAPIEE samples, it was not feasible to
differentiate between never- and ex-drinkers, as well as
between participants who could never be considered as
hazardous drinkers and those with previous history of
hazardous drinking. This might have reduced the strength
of the association between current hazardous alcohol
consumption and fatal CVD in HAPIEE men. At the same
time, the evidence from the subsample of Novosibirsk
men suggested that their drinking patterns were suffi-
ciently stable over a six-year period [8].
Finally, the baseline levels of conventional and additional
risk factors could have changed during the follow-up period
and, therefore, result in potential regression dilution bias,or underestimation of the association of interest [28]. How-
ever, the general concept of risk prediction implies focusing
on the current exposure levels, in order to estimate the
future risk of the outcome.
Consistency with other studies
The validity of our findings, despite the potential limitations
mentioned above, is supported by the general agreement
between the levels of major risk factors and CVD mortality
in HAPIEE samples and the respective national cross-
sectional estimates and trends presented in the WHO
Global InfoBase [29] and WHO systematic reviews [30-32].
Across all HAPIEE samples, the high-risk SCORE
remained a significant predictor of CVD death after ac-
counting for binge and problem drinking. We are unaware
of any published CEE/FSU or Western studies adjusting
the effects of SCORE by alcohol consumption parameters.
The absence of consistent, significant associations between
hazardous drinking and fatal CVD (negative and mixed
results for binge and problem drinking, respectively) in
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vious studies in Russian men [8-10]. However, alcohol
was not associated with increased CVD risk among par-
ticipants of the Russian Lipid Research Clinics Study [33]
and men from St. Petersburg [34] and Arkhangelsk [35].
The potential explanations of the absence of consistent
alcohol effects in our study include the relatively short
follow-up time, low numbers of atherosclerotic CVD deaths
in the currently available data (particularly in the Czech
and Polish samples), and the potential changes in drinking
behavior over time. Multiple mechanisms of adverse car-
diovascular effects of hazardous alcohol consumption
involve conventional risk factors, such as blood pressure
and cholesterol [36]. Controlling for these factors, which
are included in SCORE, might over-adjust the association
between hazardous drinking and fatal CVD. In addition,
the magnitude of the alcohol effects on cardiovascular risk
could be markedly influenced by recent episodes of
hazardous drinking, and, hence, be larger in case–control
vs. cohort studies [9,10]. Moreover, the exact mechanisms
underlying the link between hazardous drinking and
atherosclerotic vs. non-atherosclerotic fatal CVD remain un-
clear. It has been suggested that in Russia, alcohol-related
non-atherosclerotic CVD (such as alcoholic cardiomyopathy
leading to fatal arrhythmias and heart failure) and acute
alcohol poisoning could potentially be misclassified as
acute ischemic heart disease, and this may drive the as-
sociation between alcohol and cardiovascular mortality
[10,37-39]. The regional and temporal variability in the
relative impact of such misclassification on fatal CVD
rates could explain, at least partly, the mixed findings
on the role of alcohol as the determinant of CVD in
CEE/FSU. In this context, the present results should be
regarded as lacking clear evidence of an association be-
tween hazardous drinking and cardiovascular mortality,
rather than proving the absence of an association.
In our study, adding hazardous drinking parameters did
not substantially improve calibration or discrimination of
the high-risk SCORE. We were unable to identify any
CEE/FSU or Western studies which have investigated
the prognostic performance of the alcohol-extended
SCORE or another cardiovascular risk scale. Moreover,
no existing cardiovascular risk scale includes any drinking
parameters.
Conclusion
To summarise, the prospective individual-level Czech,
Polish, and Russian data from three large population
samples have shown that the high-risk SCORE signifi-
cantly predicts CVD mortality in men both before and
after adjustment for hazardous drinking characteristics. At
the same time, the improvement in calibration and discrim-
ination of the extended high-risk SCORE has been minimal.
The implications of these findings can be summarised asfollows. First, our results tentatively support the use of the
original high-risk SCORE in the male CEE/FSU popula-
tions. However, due to the mixed evidence on the associ-
ation between hazardous alcohol consumption and fatal
CVD, further research is needed on hazardous drinking
as a CVD risk factor, particularly in CEE/FSU. Future
studies may show that other measures (such as surrogate/
non-beverage drinking), when added to SCORE separately
or in combination, could improve the SCORE prognostic
performance in specific populations. Second, there is a
growing interest in the use of extended risk models among
individuals at intermediate risk [16,40,41]. The latest ESC
guidelines [2], published after our findings were obtained,
recommend the novel biomarker measurement and
cardiovascular imaging among asymptomatic adults at
“moderate risk” (SCORE ≥1% and <5%). Therefore, it
is important to investigate whether additional risk fac-
tors provide clinically and statistically significant im-
provement in the SCORE performance among people
with intermediate risk levels. Finally, our findings have
confirmed the key role of conventional risk factors. Their
control at both the population and individual levels should
reduce the CVD burden in CEE/FSU and prevent the
reversal of declining CVD rates in other populations
[2,42,43].
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